Reading Time: < 1 minute
The European Union has approved a cannabidiol or CBD-based medicine for treatment of seizures associated with severe forms of epilepsy. Epidyolex, a CBD oral solution, is the first cannabis-based medicine to be approved by the European Medicines Agency or EMA.
